ImClone begins Phase II in NSCLC

IMCL began a Phase II trial of its IMC-C225

Read the full 90 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE